Understanding why some baby boomers with Hepatitis C don't receive effective treatment
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
This study is looking into why baby boomers, especially those from different racial and ethnic backgrounds, have a hard time getting treatment for Hepatitis C, and it aims to find ways to make it easier for them to access the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10630248 on NIH RePORTER |
What this research studies
This research investigates the barriers that prevent baby boomers, particularly those from racial and ethnic minority groups, from accessing direct-acting antiviral therapy for Hepatitis C. It employs a mixed-methods approach, combining quantitative data on treatment patterns with qualitative interviews of patients and healthcare providers to identify factors contributing to disparities in care. By analyzing national and state-level data, the study aims to uncover the reasons behind the low treatment rates and propose solutions to improve access for those affected. Patients will be surveyed to gather insights on their experiences and challenges in receiving care.
Who could benefit from this research
Good fit: Ideal candidates for this research are baby boomers born between 1945 and 1965, particularly those from racial and ethnic minority backgrounds who have been diagnosed with Hepatitis C.
Not a fit: Patients who are not baby boomers or those who do not have Hepatitis C may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to life-saving Hepatitis C treatments for underserved populations.
How similar studies have performed: Previous research has shown that addressing barriers to treatment access can significantly improve health outcomes for patients with chronic diseases, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Shapiro, Martin F. — Weill Medical Coll of Cornell Univ
- Study coordinator: Shapiro, Martin F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.